Leadership

Leadership

We are driven by our mission to advance the development of new treatments.

Medidata’s journey started in 1999 when a scientist working on his first clinical trial waded through inefficiencies and delays, and knew that technology could improve the process. Over time, we’ve grown to be the leader in clinical technology, with thousands of people working towards the same goal: using the latest technology to help our life science clients bring their life-saving new treatments to the public.

Leadership Team

Tarek Sherif
Co-Founder, Co-CEO

Tarek Sherif is co-CEO and co-founder of Medidata, a Dassault Systèmes company. He has led Medidata from startup to becoming the leading global provider of cloud-based solutions to the life science industry and one of the largest technology companies founded in New York City. Medidata is the global leader in collecting and managing clinical trial data and supports trials in more than 120 countries, while defining the vertical cloud company business model. In 2020, Sherif was named chairman of the life sciences and healthcare board at Dassault Systèmes.

Sherif has more than 30 years of leadership experience in health-tech and finance. Prior to Medidata, he co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance.

Sherif received his BA in economics from Yale University in 1984 and graduated from Columbia Business School in 1991, where he earned a degree in business administration and finance. He serves as the co-chair of the Partnership Fund for New York City, which is focused on creating business opportunities and jobs for city residents. Tarek also sits on the advisory board of Students on Ice, a not-for-profit organization focused on inspiring youth through educational expeditions to the polar regions, and​ the Musculoskeletal Advisory Board at NYU Langone Medical Center​.

Glen de Vries
Co-Founder, Co-CEO

Glen de Vries is co-founder and co-CEO of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest healthcare technology acquisitions in history, Medidata became part of Dassault Systèmes. de Vries has been driving Medidata’s mission since the company’s inception in 1999, “powering smarter treatments and healthier people” by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. His publications have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He serves as a trustee of Carnegie Mellon University and is the author of The Patient Equation (de Vries & Blachman, 2020).

de Vries received his undergraduate degree in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center, and studied computer science at New York University's Courant Institute of Mathematics.

You can follow him on Twitter at @CaptainClinical

Rouven Bergmann
EVP, Chief Operating Officer

Rouven Bergmann is chief operating officer (COO) of Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Bergmann is responsible for the global operations of Medidata. He also oversees the company’s strategic finance, capital management, tax, controllership, procurement operations, expense management and treasury.

Bergmann who joined during 2015 as CFO of Medidata, a fast-growing public SaaS company led the financial strategy of growing the business from $300M to more than $700M at the time of the acquisition by Dassault Systèmes in 2019. With the acquisition, he transitioned his responsibilities as a public company CFO to COO responsible for managing the execution plan of the acquisition and day-to-day global operations of Medidata.

Prior to joining Medidata, Bergmann was CFO of SAP North America, a multi-billion dollar software business where he was responsible for overseeing all financial activities for SAP’s largest business unit. His key accomplishments include driving SAP’s transition from a traditional licensing model to SaaS and leading transformational acquisition integrations. Since joining SAP in 2005, Rouven served as chief operating officer for SAP’s global R&D organization, as well as held key leadership roles in Germany; Bangalore, India; and the U.S. in Palo Alto, Calif. and NYC.

Bergmann holds masters degrees in mechanical engineering and business administration from Technical University of Kaiserslautern in Germany, and a PhD in economics and finance from the University of Munich in Germany.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Naveen Bhateja
EVP, Chief People Officer

Naveen Bhateja is the EVP, Chief People Officer at Medidata leading all aspects of human resources including recruiting, workplace solutions, and diversity and inclusion teams globally. As a member of the senior leadership team, Bhateja operates as a business strategist and trusted advisor, and believes that people strategies empower successful business outcomes.

Prior to joining Medidata, he was global vice president of HR for Juniper Networks for five years supporting 50 countries. In this role, Bhateja led several companywide transformational initiatives including an overhaul to workforce planning process that saved over $200M in operational expenses to support reinvestment in strategic areas. Naveen’s career spans nearly 25 years at companies including GE, JP Morgan Chase, Experian and Amazon. Naveen also serves on a non-profit board for Geeks Rule and as a pro-bono account Director at Taproot Foundation.

Bhateja earned an MBA from the University of Leeds, UK and trained in design thinking at Stanford University.

Sastry Chilukuri
EVP, President of Acorn AI

As Executive Vice President of Digital and AI Solutions, Sastry Chilukuri is responsible for accelerating the development, go-to-market, and delivery of capabilities that help life science clients accelerate their innovation.

Chilukuri brings 19 years of experience in healthcare technology. He most recently was a partner at McKinsey & Company, where he worked for 12 years advising bio-pharma, medical device, technology, public sector and regulatory clients around the world. Prior to that, he worked for GE Healthcare in software engineering, product development, and operations.

His perspectives have been widely disseminated, including conferences, media and numerous publications on McKinsey Insights.

Sastry holds a Master of Business Administration from the Kellogg School of Management, Northwestern University; a Master of Science from The Ohio State University and a Bachelor of Technology (B. Tech) from the Indian Institute of Technology (BHU), Varanasi, India.

 

Anthony Costello
SVP and President, Patient Cloud

Anthony Costello is President, Patient Cloud at Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Costello leads the development of Medidata’s patient-facing activities and solutions including Virtual trials technology and strategy, Patient Cloud product apps, myMedidata patient portal, Disease Registries and Recruitment, Telehealth and Virtual Visits, and Sensor Cloud and Biomarker Discovery. 

Costello started his career in clinical research in the oncology research program at Genentech where he focused primarily on Herceptin and Avastin global research studies.  After leaving Genentech, he went on to co-found several clinical trials technology start-up companies including EDC start-up, Nextrials (acquired by PRA Health Sciences) where he was co-founder and VP of Product Development and Virtual Trials and eConsent pioneering start-up, Mytrus (acquired by Medidata) where he was co-founder and CEO. Over his career, he has focused on disruptive and innovative technology that can simplify clinical trials for patients, sites, and sponsors. 

Costello was selected as one of the PharmaVoice Top 100 Most Inspiring People in Clinical Research, has served as Chairman of the Board for the Society for Clinical Data Management, and is currently a member of the editorial advisory board for Applied Clinical Trials magazine.  He is a frequent author and presenter on topics related to the efficient use of technology in clinical research, and graduated with a BA from UC Berkeley.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Rick Goldstein
EVP, General Counsel

Rick Goldstein serves as General Counsel at Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Goldstein leads Medidata’s business-focused Legal team, which supports the company’s commercial relationships, protects the company’s intellectual property, advises on data privacy and protection regulations, identifies and mitigates enterprise risk, and guides Medidata through the cutting-edge legal issues attendant to creating transformative technology and data analysis products.

Prior to Medidata, Goldstein was a partner at Orrick, Herrington & Sutcliffe LLP, a leading global law firm, where he represented some of the world’s best-known technology and pharmaceutical companies in antitrust, intellectual property, and other complex commercial litigation and investigations.  Earlier in his career, Goldstein was Deputy General Counsel at Internet advertising pioneer DoubleClick Inc., and was a member of the commercial/legal team at Merck & Co., Inc. He received a JD from New York University School of Law, and a BA from the University of Pennsylvania.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Jackie Kent
EVP, Chief Customer Officer

Jackie Kent serves as Chief Customer Officer at Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Kent leads the newly created Customer Solutions and Success (CSS) organization, which is laser-focused on ensuring the delivery of a positive experience for customers along every step of their journey with the company. The CSS organization uses a cross-functional customer strategy to ensure that the voice of the customer is infused throughout the organization, delivering value through innovative solutions meeting the most important needs of the industry and patients. 

Prior to joining Medidata, Kent spent 28 years at Eli Lilly, starting with technical IT and moving into leadership roles across Clinical Development. She developed a comprehensive knowledge of information technology, clinical trial design and execution, as well as clinical trial supply planning. Kent also had accountability for the IT systems that supported these teams, including the Clinical Trial MRP system (SAP) and the Lilly IRT system.

Kent serves as vice-chair of the Association of Clinical Research Organizations (ACRO) and is a member of the Society of Clinical Research Sites (SCRS) Leadership Council. She received her B.S. in Computer Science from Butler University.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Dr. Rama Kondru
EVP, Chief Technology Officer and Head of Product

Rama Kondru serves as Chief Technology Officer and Head of Product at Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Kondru leads a unified R&D organization — Products and Technology — with a focus on analytics, architecture, and patient centricity, which drive value for Medidata’s customers and positive outcomes for patients.

An innovative and strategically focused executive with over 20 years of experience in pharma, medical devices, data science, and academia, Kondru helps design and develop technology products that deliver enhanced patient outcomes and experiences. Prior to Medidata, he served as CIO for Janssen Americas, a Johnson and Johnson company, and was vice president and CIO for R&D and Innovation in Medical Devices. In addition, he held leadership roles at UCB Pharma and Hoffmann-La Roche.

Kondru is well recognized in the industry, having received multiple awards and named author on over 25 patents and 30 peer-reviewed scientific publications. He has an undergraduate degree from the Indian Institute of Technology, Mumbai and a Ph.D. from the University of Pittsburgh. He completed post-doctoral training at the University of Pittsburgh Medical School and served as an adjunct professor at Duke University.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Wendy Lurrie
SVP, Global Marketing

Wendy Lurrie serves as senior vice president of global marketing at Medidata. She has responsibility for all aspects of how Medidata markets and communicates its portfolio of brands to key audiences and constituencies. This includes the creation of innovative marketing strategies that build the brand and business, and partnering with sales and services to meet revenue goals.

She is a proven healthcare marketing leader with unmatched experience in driving innovation, growth, culture, and results. Prior to Medidata, Lurrie spent over 30 years across the full spectrum of marketing disciplines, including brand, direct marketing, CRM, digital marketing, and integrated marketing. Most recently she was the president of gyro NY and the founder of gyro:human, the agency’s first healthcare practice. Lurrie has also held senior positions at Grey and FCB, and co-founded SPUR partners, a marketing and strategy consultancy. 

Lurie was named a Working Mother of the Year in 2008, and has written widely published articles about healthcare and B2B marketing. Her bachelor's degree and graduate work were in english and linguistics at New York University. 

Ludovic Monchal
Chief Financial Officer

Ludovic Monchal is the chief financial officer (CFO) of Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), which powers smarter treatments and healthier people.

Monchal is responsible for overseeing the company’s finance activities. These include commercial finance, financial planning and analysis, controllership, expense management, procurement, and tax. As a member of the senior leadership team, Monchal operates as a trusted advisor to propose and implement the best financial strategies in accordance with the company's strategic objectives.

Since joining Dassault Systèmes in 1999, Monchal has held various key finance leadership roles, as CFO for several divisions in the US and in France and most recently as vice president for Corporate Financial Planning and Analysis, a position he held since 2013. He led a major transformation of its global financial planning and analysis function, which included implementing a new Enterprise Performance Management infrastructure, enabling Dassault Systèmes’ growth from 2.0 to 4.5 billion Euros in revenue. Prior to joining Dassault Systèmes, he was an Audit Manager and then a Transaction Services Director in the Paris Office of Deloitte.

Monchal received his BS in Economics and holds a Master’s degree in Financial Engineering from the KEDGE business school.

Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,700+ customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.

Michael Pray
EVP, Chief Commercial Officer, Life Sciences

Michael Pray serves as Chief Commercial Officer of Life Science Engagement at Dassault Systèmes. Pray leads the commercial go-to-market team responsible for global sales of Dassault Systèmes brands and solutions into the Life Sciences sector. 

With more than 25 years of industry experience, Pray has a proven track record of building and scaling high-performing sales teams in both start-up and high-growth environments. Since 2016, Pray was EVP and General Manager of Medidata's global commercial organization prior to its acquisition by Dassault Systèmes.  

Pray previously served as chief revenue officer of Tangoe, a global technology company that provides cloud solutions to effectively manage IT assets and services. Before Tangoe, he spent 14 years within IBM's software group that included a series of executive positions with roles of increasing responsibility. He served as VP of worldwide analytic solution sales, where he was responsible for sales, technical sales and channels that drove over $1.5B in annual revenue. 

Pray earned a bachelor's degree from the University of Michigan in Ann Arbor.